Movatterモバイル変換

[0]ホーム
URL:

GB0700432D0 - Therapeutic compounds - Google Patents

Therapeutic compounds

Info

Publication number
GB0700432D0
GB0700432D0GBGB0700432.8AGB0700432AGB0700432D0GB 0700432 D0GB0700432 D0GB 0700432D0GB 0700432 AGB0700432 AGB 0700432AGB 0700432 D0GB0700432 D0GB 0700432D0
Authority
GB
United Kingdom
Prior art keywords
diseases
cancer
treatment
cardiovascular diseases
therapeutic compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0700432.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=37809722&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0700432(D0)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpAfiledCriticalIstituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority to GBGB0700432.8ApriorityCriticalpatent/GB0700432D0/en
Publication of GB0700432D0publicationCriticalpatent/GB0700432D0/en
Priority to CN200780012001.6Aprioritypatent/CN101415686B/en
Priority to US12/225,857prioritypatent/US20090275619A1/en
Priority to CA2647545Aprioritypatent/CA2647545C/en
Priority to AU2007232297Aprioritypatent/AU2007232297B2/en
Priority to JP2009503667Aprioritypatent/JP4611441B2/en
Priority to EP07733600.6Aprioritypatent/EP2007733B1/en
Priority to PCT/GB2007/050177prioritypatent/WO2007113596A1/en
Priority to EP08702101Aprioritypatent/EP2109608B1/en
Priority to AT08702101Tprioritypatent/ATE502933T1/en
Priority to EA200970674Aprioritypatent/EA016079B1/en
Priority to PCT/GB2008/050018prioritypatent/WO2008084261A1/en
Priority to JP2009545240Aprioritypatent/JP4611444B2/en
Priority to PT111573697Tprioritypatent/PT2336120E/en
Priority to US12/006,993prioritypatent/US8071623B2/en
Priority to RS20190600Aprioritypatent/RS58936B1/en
Priority to UAA200908335Aprioritypatent/UA97658C2/en
Priority to BRPI0806245-5Aprioritypatent/BRPI0806245B1/en
Priority to PL11157369Tprioritypatent/PL2336120T3/en
Priority to PE2008000097Aprioritypatent/PE20081558A1/en
Priority to TW097100730Aprioritypatent/TWI528961B/en
Priority to PT08702101Tprioritypatent/PT2109608E/en
Priority to DE602008005711Tprioritypatent/DE602008005711D1/en
Priority to EP14176452.2Aprioritypatent/EP2805945B1/en
Priority to NZ578256Aprioritypatent/NZ578256A/en
Priority to AU2008204380Aprioritypatent/AU2008204380B2/en
Priority to SI200830240Tprioritypatent/SI2109608T1/en
Priority to ARP080100061Aprioritypatent/AR064777A1/en
Priority to ES14176452Tprioritypatent/ES2728199T3/en
Priority to CL200800046Aprioritypatent/CL2008000046A1/en
Priority to HK09110676.1Aprioritypatent/HK1131137B/en
Priority to MYPI20092876Aprioritypatent/MY147789A/en
Priority to MEP-2019-147Aprioritypatent/ME03481B/en
Priority to PT14176452Tprioritypatent/PT2805945T/en
Priority to SI200831266Tprioritypatent/SI2336120T1/en
Priority to EP19164594.4Aprioritypatent/EP3536690A1/en
Priority to EP11157369.7Aprioritypatent/EP2336120B1/en
Priority to KR1020097014520Aprioritypatent/KR101591656B1/en
Priority to SI200832067Tprioritypatent/SI2805945T1/en
Priority to ES11157369.7Tprioritypatent/ES2509115T3/en
Priority to DK08702101.0Tprioritypatent/DK2109608T3/en
Priority to MX2009007200Aprioritypatent/MX2009007200A/en
Priority to DK11157369.7Tprioritypatent/DK2336120T3/en
Priority to HR20110447Tprioritypatent/HRP20110447T1/en
Priority to LTEP14176452.2Tprioritypatent/LT2805945T/en
Priority to CN2008800019265Aprioritypatent/CN101578279B/en
Priority to DK14176452.2Tprioritypatent/DK2805945T3/en
Priority to PL14176452Tprioritypatent/PL2805945T3/en
Priority to CA2674436Aprioritypatent/CA2674436C/en
Priority to HUE14176452prioritypatent/HUE044513T2/en
Priority to ES08702101Tprioritypatent/ES2362214T3/en
Priority to RS20110236Aprioritypatent/RS51780B/en
Priority to PL08702101Tprioritypatent/PL2109608T3/en
Priority to GEAP200811413Aprioritypatent/GEP20115337B/en
Priority to ZA200903898Aprioritypatent/ZA200903898B/en
Priority to IL199264Aprioritypatent/IL199264A/en
Priority to HN2009001260Aprioritypatent/HN2009001260A/en
Priority to SV2009003321Aprioritypatent/SV2009003321A/en
Priority to DO2009000170Aprioritypatent/DOP2009000170A/en
Priority to GT200900190Aprioritypatent/GT200900190A/en
Priority to CR10910Aprioritypatent/CR10910A/en
Priority to CO09068415Aprioritypatent/CO6210732A2/en
Priority to NI200900135Aprioritypatent/NI200900135A/en
Priority to EC2009009484Aprioritypatent/ECSP099484A/en
Priority to TNP2009000286Aprioritypatent/TN2009000286A1/en
Priority to MA32111Aprioritypatent/MA31554B1/en
Priority to HK11108534.3Aprioritypatent/HK1154386B/en
Priority to US13/091,427prioritypatent/US20110201657A1/en
Priority to CY20111100595Tprioritypatent/CY1111584T1/en
Priority to NL300937Cprioritypatent/NL300937I2/en
Priority to LTPA2018009Cprioritypatent/LTC2109608I2/en
Priority to LU00072Cprioritypatent/LUC00072I2/en
Priority to HUS1800022Cprioritypatent/HUS1800022I1/en
Priority to NO2018016Cprioritypatent/NO2018016I1/en
Priority to CY2018014Cprioritypatent/CY2018014I1/en
Priority to HRP20190972TTprioritypatent/HRP20190972T1/en
Priority to CY20191100692Tprioritypatent/CY1121751T1/en
Ceasedlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts, stereoisomers or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory discuses, reperfusion injuries, ischemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes, neurodegenerative diseases, retroviral infection, retinal damage or skin senescence and UV-induced skin damage, and as chemo and/or radiosensitizers for cancer treatment.
GBGB0700432.8A2006-04-032007-01-10Therapeutic compoundsCeasedGB0700432D0 (en)

Priority Applications (77)

Application NumberPriority DateFiling DateTitle
GBGB0700432.8AGB0700432D0 (en)2007-01-102007-01-10Therapeutic compounds
CN200780012001.6ACN101415686B (en)2006-04-032007-04-02Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors
US12/225,857US20090275619A1 (en)2006-04-032007-04-02Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
CA2647545ACA2647545C (en)2006-04-032007-04-02Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
AU2007232297AAU2007232297B2 (en)2006-04-032007-04-02Amide substituted indazole and benzotriazole derivatives as poly(ADP-ribose)polymerase (PARP) inhibitors
JP2009503667AJP4611441B2 (en)2006-04-032007-04-02 Amide-substituted indazole and benzotriazole derivatives as poly (ADP-ribose) polymerase (PARP) inhibitors
EP07733600.6AEP2007733B1 (en)2006-04-032007-04-02Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
PCT/GB2007/050177WO2007113596A1 (en)2006-04-032007-04-02Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
EP08702101AEP2109608B1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
AT08702101TATE502933T1 (en)2007-01-102008-01-08 AMIDE-SUBSTITUTED INDAZOLES AS POLY-(ADP-RIBOSE)-POLYMERASE (PARP) INHIBITORS
EA200970674AEA016079B1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PCT/GB2008/050018WO2008084261A1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
JP2009545240AJP4611444B2 (en)2007-01-102008-01-08 Amide substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
PT111573697TPT2336120E (en)2007-01-102008-01-08Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
US12/006,993US8071623B2 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
RS20190600ARS58936B1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
UAA200908335AUA97658C2 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
BRPI0806245-5ABRPI0806245B1 (en)2007-01-102008-01-08 Compounds of formula i and their uses
PL11157369TPL2336120T3 (en)2007-01-102008-01-08Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PE2008000097APE20081558A1 (en)2007-01-102008-01-08 INDAZOLES SUBSTITUTED WITH AMIDE AS POLY INHIBITORS (ADP-RIBOSE) POLYMERASE (PARP)
TW097100730ATWI528961B (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PT08702101TPT2109608E (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
DE602008005711TDE602008005711D1 (en)2007-01-102008-01-08 AMIDSUBSTITUTED INDAZOLE AS A POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR
EP14176452.2AEP2805945B1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
NZ578256ANZ578256A (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
AU2008204380AAU2008204380B2 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
SI200830240TSI2109608T1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
ARP080100061AAR064777A1 (en)2007-01-102008-01-08 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
ES14176452TES2728199T3 (en)2007-01-102008-01-08 Amide substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
CL200800046ACL2008000046A1 (en)2007-01-102008-01-08 COMPOUNDS DERIVED FROM 2- (4-PIPERIDIN-3-IL-FENIL) -7-AMIDO-2,7A-DIHIDRO-1H-INDAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT OR PREVENT CANCER, INFLAMMATORY DISEASES, REPERFUSION INJURIES, AFFECT
HK09110676.1AHK1131137B (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
MYPI20092876AMY147789A (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
MEP-2019-147AME03481B (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PT14176452TPT2805945T (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
SI200831266TSI2336120T1 (en)2007-01-102008-01-08Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
EP19164594.4AEP3536690A1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
EP11157369.7AEP2336120B1 (en)2007-01-102008-01-08Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
KR1020097014520AKR101591656B1 (en)2007-01-102008-01-08 Amides as poly (ADP-ribose) polymerase inhibitors (PARP)
SI200832067TSI2805945T1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
ES11157369.7TES2509115T3 (en)2007-01-102008-01-08 Combinations containing amide substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
DK08702101.0TDK2109608T3 (en)2007-01-102008-01-08 Amide-substituted indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
MX2009007200AMX2009007200A (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors.
DK11157369.7TDK2336120T3 (en)2007-01-102008-01-08 COMBINATIONS CONTAINING AMID-SUBSTITUTED INDAZOLES AS POLY (ADP-RIBOSE) POLYMERASE (PARP) INHIBITORS
HR20110447THRP20110447T1 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
LTEP14176452.2TLT2805945T (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
CN2008800019265ACN101578279B (en)2007-01-102008-01-08 Amide-substituted indazoles as poly(ADP-ribose) polymerase (PARP) inhibitors
DK14176452.2TDK2805945T3 (en)2007-01-102008-01-08 AMID-SUBSTITUTED INDAZOLS AS POLY (ADP-RIBOSE) POLYMERASE (PARP) REQUESTS
PL14176452TPL2805945T3 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
CA2674436ACA2674436C (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
HUE14176452HUE044513T2 (en)2007-01-102008-01-08Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
ES08702101TES2362214T3 (en)2007-01-102008-01-08 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP).
RS20110236ARS51780B (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PL08702101TPL2109608T3 (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
GEAP200811413AGEP20115337B (en)2007-01-102008-01-08Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
ZA200903898AZA200903898B (en)2007-01-102009-06-04Amide substituted indazoles as poly (ADP-Ribose)polymerase (PARP) inhibitors
IL199264AIL199264A (en)2007-01-102009-06-09Amide substituted indazole compounds and use thereof for manufacture of medicaments for treatment of conditions that can be ameliorated by inhibition of poly (adp-ribose)polymerase (parp)
HN2009001260AHN2009001260A (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADPRIBOSE) POLYMERASE (PARP)
SV2009003321ASV2009003321A (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
DO2009000170ADOP2009000170A (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
GT200900190AGT200900190A (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
CR10910ACR10910A (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMIDA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
CO09068415ACO6210732A2 (en)2007-01-102009-07-02 INDAZOLS REPLACED WITH AMINA AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP)
NI200900135ANI200900135A (en)2007-01-102009-07-02 INDAZOLES SUBSTITUTED WITH AMIDE AS POLY INHIBITORS (ADP-RIBOSA) POLYMERASE (PARP).
EC2009009484AECSP099484A (en)2007-01-102009-07-03 INDAZOLS REPLACED WITH AMIDA AS INHIBITORS OF
TNP2009000286ATN2009000286A1 (en)2007-01-102009-07-03Amide substituted indazoles as poly (adp-ribose)polymerase (parp) inhibitors
MA32111AMA31554B1 (en)2007-01-102009-07-20 AMIDE-SUBSTITUTED INDAZOLES AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERASE (PARP)
HK11108534.3AHK1154386B (en)2007-01-102009-11-14Combinations containing amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
US13/091,427US20110201657A1 (en)2006-04-032011-04-21Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
CY20111100595TCY1111584T1 (en)2007-01-102011-06-22 AMIDO-SUBSTITUTED INDIAZOLS AS POLYMER (ADP-RIVOZIS) POLYMERIZATION INHIBITORS (PARP)
NL300937CNL300937I2 (en)2007-01-102018-04-26 Niraparib, or a tautomer thereof, optionally in the form of a pharmaceutically acceptable salt, in particular the tosylate or a hydrate, more in particular the tosylate monohydrate
LTPA2018009CLTC2109608I2 (en)2007-01-102018-04-30 The amide is replaced by indazoles as poly (ADP-ribose) polymerase (PARP) inhibitors
LU00072CLUC00072I2 (en)2007-01-102018-05-03 Niraparib or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, in particular tosylate or a hydrate, particularly tosylate monohydrate
HUS1800022CHUS1800022I1 (en)2007-01-102018-05-07Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
NO2018016CNO2018016I1 (en)2007-01-102018-05-14 Niraparib or a pharmaceutically acceptable salt, stereoisomer or tautomer thereof, especially the tosylate or a hydrate, especially the tosylate monohydrate
CY2018014CCY2018014I1 (en)2007-01-102018-05-15 AMIDO- SUBSTITUTED INDAZOLES AS INHIBITORS OF POLY (ADP-RIBOSE) POLYMERIZATION (PARP)
HRP20190972TTHRP20190972T1 (en)2007-01-102019-05-28Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
CY20191100692TCY1121751T1 (en)2007-01-102019-07-02 AMIDO- SUBSTITUTED INDAZOLES AS INHIBITORS OF POLY(ADP-RIBOSE) POLYMERIZATION (PARP)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
GBGB0700432.8AGB0700432D0 (en)2007-01-102007-01-10Therapeutic compounds

Publications (1)

Publication NumberPublication Date
GB0700432D0true GB0700432D0 (en)2007-02-21

Family

ID=37809722

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GBGB0700432.8ACeasedGB0700432D0 (en)2006-04-032007-01-10Therapeutic compounds

Country Status (21)

CountryLink
CN (1)CN101578279B (en)
AT (1)ATE502933T1 (en)
CR (1)CR10910A (en)
DE (1)DE602008005711D1 (en)
DK (2)DK2336120T3 (en)
ES (3)ES2362214T3 (en)
GB (1)GB0700432D0 (en)
HN (1)HN2009001260A (en)
HU (1)HUE044513T2 (en)
LT (1)LT2805945T (en)
LU (1)LUC00072I2 (en)
ME (1)ME03481B (en)
MY (1)MY147789A (en)
NI (1)NI200900135A (en)
NZ (1)NZ578256A (en)
PE (1)PE20081558A1 (en)
PT (3)PT2805945T (en)
SI (2)SI2336120T1 (en)
TW (1)TWI528961B (en)
UA (1)UA97658C2 (en)
ZA (1)ZA200903898B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CN106496187A (en)*2016-09-142017-03-15陕西科技大学A kind of synthetic method for preparing PARP inhibitor Niraparib
CN106432188A (en)*2016-09-172017-02-22青岛辰达生物科技有限公司Preparation method of anti-cancer drug 2-[4-((3S)-3-Piperidinyl) phenyl]-2H-Indazole-7-Formamide
CN106432187A (en)*2016-09-172017-02-22青岛云天生物技术有限公司Chiral resolution method of 2-[4-(-3-piperidyl)phenyl]-2H-indazole-7-formamide
CN106632244A (en)*2016-09-302017-05-10陕西科技大学A novel synthetic method for preparing an anticancer medicine Niraparib
CN106467513A (en)*2016-09-302017-03-01陕西科技大学A kind of synthetic method preparing Niraparib
CN108201537A (en)*2016-12-162018-06-26苏州苏融生物医药有限公司A kind of Ni Lapani sustained and controlled release medicaments composition and application thereof
WO2018183349A1 (en)*2017-03-272018-10-04Tesaro, Inc.Niraparib formulations
CN109081828B (en)*2017-06-142021-03-26上海时莱生物技术有限公司Poly (ADP-ribose) polymerase inhibitor, preparation method and application
CN111278433A (en)2017-09-262020-06-12特沙诺有限公司Nilaparib formulations
CN108084157A (en)*2018-02-122018-05-29安庆奇创药业有限公司A kind of synthetic method of Ni Lapani
CN108203404A (en)*2018-03-022018-06-26上海博邦医药科技有限公司(R) synthetic method of -3- Phenylpiperidines or/and the chiral intermediate of (S) -3- Phenylpiperidines and Ni Lapani
US20240016775A1 (en)2020-02-242024-01-18Fukang (Shanghai) Health Technology Co., LtdAnti-coronavirus application of poly adp ribose polymerase inhibitor
CN115611860B (en)*2021-07-132024-06-11上海博璞诺科技发展有限公司Method for synthesizing nilaparib

Also Published As

Publication numberPublication date
CN101578279B (en)2013-07-17
MY147789A (en)2013-01-31
DK2109608T3 (en)2011-07-11
SI2109608T1 (en)2011-07-29
LT2805945T (en)2019-06-25
TW200836731A (en)2008-09-16
ATE502933T1 (en)2011-04-15
ES2509115T3 (en)2014-10-17
HN2009001260A (en)2012-03-26
DK2336120T3 (en)2014-10-06
DE602008005711D1 (en)2011-05-05
ME03481B (en)2020-01-20
UA97658C2 (en)2012-03-12
HUE044513T2 (en)2019-10-28
ES2362214T3 (en)2011-06-29
PE20081558A1 (en)2008-10-30
PT2336120E (en)2014-10-01
NZ578256A (en)2011-12-22
CR10910A (en)2010-01-19
CN101578279A (en)2009-11-11
ZA200903898B (en)2010-04-28
PT2109608E (en)2011-05-30
NI200900135A (en)2010-08-30
TWI528961B (en)2016-04-11
PT2805945T (en)2019-06-06
SI2336120T1 (en)2014-10-30
LUC00072I2 (en)2018-07-04
ES2728199T3 (en)2019-10-22

Similar Documents

PublicationPublication DateTitle
GB0700432D0 (en)Therapeutic compounds
MX2009007200A (en)Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors.
MX2010005070A (en)Pyridazinone derivatives as parp inhibitors.
WO2007138351A3 (en)Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
MX2012002179A (en)Heterocyclic oxime compounds.
WO2010045251A3 (en)Spiro-oxindole compounds and their use as therapeutic agents
MX2011011854A (en)Dihydropyrimidinones for use as bace2 inhibitors.
WO2008103277A3 (en)Nitrogen-containing heterocyclyl ketones and their use as c-met inhibitors
MX339759B (en)Compounds for the treatment/prevention of ocular inflammatory diseases.
BR112015002293A2 (en) dihydropyridone pi as xia factor inhibitors
WO2011147951A8 (en)Cycloamino derivatives as gpr119 agonists
WO2008017883A3 (en)4-oxo-4,5-dihydropyrrolo[1,2-a] quinoxaline derivatives as inhibitors of poly(adp-ribose)polymerase(parp)
MX2012007582A (en)4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds.
MX2011013869A (en)Anthelmintic agents and their use.
GB201114389D0 (en)Novel compounds
PH12015500418A1 (en)Pyridine derivative and medicine

Legal Events

DateCodeTitleDescription
ATApplications terminated before publication under section 16(1)
[8]ページ先頭
©2009-2025 Movatter.jp